CPRX Q4 2019 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M+5924.5% YoY

Gross Profit

$26M85.4% margin

Operating Income

$8M26.6% margin

Net Income

$8M26.3% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

-2.5%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$12M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$112M

Total Liabilities

$25M

Stockholders' Equity

$88M

Cash & Equivalents

$90M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$500,000	+5924.5%
Gross Profit	$26M	-$8M	+424.9%
Operating Income	$8M	-$15M	+153.9%
Net Income	$8M	-$14M	+154.7%